TYK Medicines, Inc
TYK Medicines, Inc (HKSE: 2410) is trading at HK$4.09, about ₹50 at today's HKD/INR rate, as of 28 Sep 2026, 4:08 AM ET, down 2.15% today. Indian residents can buy TYK Medicines from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
HK$3.96
Today's high
HK$4.58
52 week low
HK$2.41
52 week high
HK$18.50
2410 opened at HK$4.58, closed previously at HK$4.18, and has traded between HK$2.41 and HK$18.50 over the past 52 weeks.
About
TYK Medicines, Inc. is a biopharmaceutical firm in the clinical development phase, dedicated to identifying, obtaining, advancing, and bringing to market innovative treatments for significant unmet needs in oncology. The company's primary drug candidate, TY-9591, is a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI). It is being developed to treat non-small cell lung cancer (NSCLC) with EGFR mutations that has metastasized to the brain, as well as locally advanced or metastatic NSCLC characterized by the EGFR L858R mutation. Beyond its lead candidate, TYK Medicines maintains a diverse pipeline of other investigational therapies. These include TY-302, an oral cyclin-dependent kinase (CDK) 4/6 inhibitor designed for solid tumors such as breast and prostate cancer. Another compound, TY-2136b, is an oral ROS proto-oncogene 1/neurotrophic tyrosine receptor kinase inhibitor also aimed at solid tumors. The company is advancing TY-2699a, a selective CDK7 inhibitor, and TY-0540, a selective CDK2/4/6 inhibitor, both targeting advanced or metastatic solid malignancies. Further, the pipeline features TY-4028, an oral exon 20 insertion tyrosine kinase inhibitor (TKI) specifically addressing locally advanced or metastatic non-small cell lung cancer (NSCLC) with EGFR exon 20 or HER2 exon 20 insertions. TY-1091 is a potent and selective rearranged during transfection proto-oncogene (RET) inhibitor, under development for advanced NSCLC with RET gene fusion, advanced medullary thyroid cancer with RET gene mutation, and other solid tumors presenting RET gene alterations. Other promising programs include TY-1054, an oral yes-associated protein-transcriptional enhanced associate domain inhibitor for various cancers; TY-1210, a selective CDK2 inhibitor for solid tumors; TY-0609, a selective CDK4 inhibitor also for cancer therapy; and TY-3200, an innovative EGFR degrader. Established in 2017, the enterprise operates from its main office located in Huzhou, China.
Key statistics
Avg. volume
4.49M
Market cap
HK$1.55B
P/E Ratio
-6.18
Price-to-sales ratio
0.00
Enterprise value
CN¥1.27B
Free cash flow yield
-20.30%
Debt-to-equity ratio
0.57
Return on equity
-77.60%
ROIC
-57.51%
Beta
2.20
Dividend yield
0.00%
Last dividend
HK$0.00
Financial overview
Revenue
CN¥0.00
Earnings per share
-CN¥0.78
Free cash flow
-CN¥255.18M
Net profit margin
0.00%
Gross margin
0.00%
EBITDA
-CN¥289.82M
Revenue growth
-100.00%
Similar securities
This is not an investment recommendation
How to buy TYK Medicines from India
Indian residents can buy TYK Medicines shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to HKD.
Search for TYK Medicines and place an order
Find TYK Medicines by name or by its ticker, 2410, and choose an order type. Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share. TYK Medicines trades 7:00 am – 1:30 pm IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your TYK Medicines position in HKD and INR. TYK Medicines pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Read the full guide: how to invest in TYK Medicines from India
Trading and taxes when buying TYK Medicines from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm HKT
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneTYK Medicines does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
FAQs
Can Indian residents buy TYK Medicines stock?
Yes. TYK Medicines (2410) has been listed on the Hong Kong Stock Exchange since 2024, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to HKD. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one TYK Medicines share cost in rupees?
One TYK Medicines share is HK$4.09 — about ₹50 at an HKD/INR rate of 12.24 on 27 Sep 2026. Both the TYK Medicines price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying TYK Medicines from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
What is the minimum I can buy of TYK Medicines?
Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share.
How are gains on TYK Medicines shares taxed in India?
Hong Kong generally does not levy capital gains tax on non-resident individual investors for HKEX-listed stocks, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the HKD/INR rate on the purchase and the sale date, so the rupee move counts alongside the TYK Medicines price. Paasa issues a capital-gains statement for your return.
Does TYK Medicines pay a dividend?
No. TYK Medicines does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade TYK Medicines from India?
The Hong Kong Stock Exchange trades 7:00 am – 1:30 pm IST in Indian time. It also halts for lunch, 9:30 am – 10:30 am IST. Orders can only execute during that window.
Is TYK Medicines a Hong Kong SAR China company, and does that change how it is taxed?
TYK Medicines trades on the Hong Kong Stock Exchange in HKD, but the company is domiciled in China. TYK Medicines trades as an ordinary share listed directly in Hong Kong, not a depositary receipt. Your India-side capital-gains treatment is the same either way.
Do I have to declare TYK Medicines shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your TYK Medicines holding, its cost and its closing value.
How do I sell TYK Medicines and bring the money back to India?
You sell during market hours (7:00 am – 1:30 pm IST) and the proceeds settle in HKD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.